Novo Nordisk
NVO
NVO
883 hedge funds and large institutions have $14.7B invested in Novo Nordisk in 2021 Q4 according to their latest regulatory filings, with 149 funds opening new positions, 263 increasing their positions, 293 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 802 → 883 (+81)
0.04% less ownership
Funds ownership: 14.91% → 14.87% (-0.04%)
10% less repeat investments, than reductions
Existing positions increased: 263 | Existing positions reduced: 293
Holders
883
Holding in Top 10
23
Calls
$169M
Puts
$79.7M
Top Buyers
| 1 | +$278M | |
| 2 | +$59.8M | |
| 3 | +$58.8M | |
| 4 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$22.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$20M |
Top Sellers
| 1 | -$283M | |
| 2 | -$61.5M | |
| 3 | -$49.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$35M |
| 5 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$33.1M |